Related Experiment Video

Updated: Aug 15, 2026

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers
08:13

Using the Chicken Chorioallantoic Membrane In Vivo Model to Study Gynecological and Urological Cancers

Published on: January 28, 2020

[Role of human leukocyte antigen-G small interference RNA in a choriocarcinoma cell line]

Chun-ling Chen1, Qin-ping Liao

  • 1Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.

Zhonghua Fu Chan Ke Za Zhi
|October 6, 2005
PubMed
Abstract

Insights

Small interference RNA targeting human leukocyte antigen-G (HLA-G) effectively reduced HLA-G expression in choriocarcinoma cells. This downregulation inhibited tumor cell growth, highlighting HLA-G's role in choriocarcinoma development.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Oncology

Context:

  • Choriocarcinoma is a gestational trophoblastic neoplasm.
  • Human Leukocyte Antigen-G (HLA-G) is a non-classical MHC class I molecule.
  • Aberrant HLA-G expression is implicated in various cancers, including choriocarcinoma.

Purpose:

  • To investigate the role of HLA-G in choriocarcinoma development.
  • To assess the efficacy of small interference RNA (siRNA) in downregulating HLA-G expression in choriocarcinoma cells.
  • To evaluate the impact of HLA-G downregulation on choriocarcinoma cell proliferation.

Summary:

  • A double-stranded siRNA targeting HLA-G was synthesized and transfected into the JEG-3 choriocarcinoma cell line.
  • Real-time RT-PCR and Western blot confirmed significant downregulation of HLA-G mRNA and protein levels.
  • siRNA-mediated HLA-G knockdown resulted in inhibited proliferation of choriocarcinoma cells.

Impact:

  • Demonstrates that HLA-G plays a critical role in choriocarcinoma progression.
  • Provides a potential therapeutic strategy targeting HLA-G for choriocarcinoma treatment.
  • Suggests HLA-G as a prognostic biomarker for choriocarcinoma.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...